Review



ubiquitinated e cadherin  (Abcam)


Bioz Verified Symbol Abcam is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Abcam ubiquitinated e cadherin
    RNF43 was associated with <t>E-cadherin</t> downregulation in lung adenocarcinoma. a , Total protein extracts from cancerous (left) and paracancerous (right) tissues were analyzed by antibodies and processed for high-throughput immunoblotting using protein antibody microarrays consisting of 650 antibodies. b , The microarray analysis described in A unveiled the differences in protein expression between cancerous and paracancerous tissues, revealing significant upregulation (red color) of RNF43 and p-Src in lung adenocarcinoma. The green and yellow colors represent equal signals and downregulation (E-cad) in lung adenocarcinoma. c , Luciferase-based siRNA library screen for human E3 ligases identified multiple E3 candidates upon knockdown in SUM-E-cad-Luc/R-Luc cells, which increased luciferase activity by more than 4-fold. d , Immunohistochemical staining for RNF43 and E-cadherin was performed at high magnification (× 400)
    Ubiquitinated E Cadherin, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 5943 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microarray+and+high-throughput+sequencing+database/Anti-E+Cadherin+antibody/pmc06613270-48-16-27
    Average 99 stars, based on 5943 article reviews
    ubiquitinated e cadherin - by Bioz Stars, 2026-11
    99/100 stars

    Images

    1) Product Images from "RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma"

    Article Title: RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma

    Journal: BMC Cancer

    doi: 10.1186/s12885-019-5880-1

    RNF43 was associated with E-cadherin downregulation in lung adenocarcinoma. a , Total protein extracts from cancerous (left) and paracancerous (right) tissues were analyzed by antibodies and processed for high-throughput immunoblotting using protein antibody microarrays consisting of 650 antibodies. b , The microarray analysis described in A unveiled the differences in protein expression between cancerous and paracancerous tissues, revealing significant upregulation (red color) of RNF43 and p-Src in lung adenocarcinoma. The green and yellow colors represent equal signals and downregulation (E-cad) in lung adenocarcinoma. c , Luciferase-based siRNA library screen for human E3 ligases identified multiple E3 candidates upon knockdown in SUM-E-cad-Luc/R-Luc cells, which increased luciferase activity by more than 4-fold. d , Immunohistochemical staining for RNF43 and E-cadherin was performed at high magnification (× 400)
    Figure Legend Snippet: RNF43 was associated with E-cadherin downregulation in lung adenocarcinoma. a , Total protein extracts from cancerous (left) and paracancerous (right) tissues were analyzed by antibodies and processed for high-throughput immunoblotting using protein antibody microarrays consisting of 650 antibodies. b , The microarray analysis described in A unveiled the differences in protein expression between cancerous and paracancerous tissues, revealing significant upregulation (red color) of RNF43 and p-Src in lung adenocarcinoma. The green and yellow colors represent equal signals and downregulation (E-cad) in lung adenocarcinoma. c , Luciferase-based siRNA library screen for human E3 ligases identified multiple E3 candidates upon knockdown in SUM-E-cad-Luc/R-Luc cells, which increased luciferase activity by more than 4-fold. d , Immunohistochemical staining for RNF43 and E-cadherin was performed at high magnification (× 400)

    Techniques Used: High Throughput Screening Assay, Western Blot, Microarray, Expressing, Luciferase, Activity Assay, Immunohistochemical staining, Staining

    Activated c-Src mediated the ubiquitination and degradation of E-cadherin in lung adenocarcinoma cells. a , Immunoblot analysis of c-Src, pY416-Src (p-Src), E-cadherin (E-cad), RNF43, Hakai and β-actin in the human lung adenocarcinoma cell lines A549, NCI-H522, NCI-H1975, NCI-H1623 and NCI-H2073. b , A549 cells were stably transfected with lentivirus containing control or Caspase-8 shRNA (Cap8 KD). Caspase-8, p-Src, c-Src, E-cad and β-actin in total cell lysates (TCLs) were detected by western blot. c , Caspase-8-deficient H522 cells were stably transfected with a control vector or wild-type Caspase-8 via adenovirus. Caspase-8, p-Src, c-Src, E-cad and β-actin in TCLs were detected by western blot. d , The TCLs of A549 and H522 cells in which c-Src was activated were subjected to immunoprecipitation (IP) using an anti-E-cadherin antibody. Ubiquitinated (Ubi-) E-cadherin was detected by western blot ( upper blot ). The blot was then stripped and reprobed for RNF43 ( second from upper panel ). RNF43, E-cadherin and β-actin were in TCLs detected by western blot ( lower blot ). e , A549 cells were allowed to attach to dishes for 12 h and then assessed by confocal microscopy using antibodies against E-cadherin and RNF43. Scale bars, 10 μm. f , E-cadherin mRNA was examined in A549 + control/Caspase-8 shRNA cells (Casp8 KD) and in H522 + control vector/wild-type Caspase-8 cells
    Figure Legend Snippet: Activated c-Src mediated the ubiquitination and degradation of E-cadherin in lung adenocarcinoma cells. a , Immunoblot analysis of c-Src, pY416-Src (p-Src), E-cadherin (E-cad), RNF43, Hakai and β-actin in the human lung adenocarcinoma cell lines A549, NCI-H522, NCI-H1975, NCI-H1623 and NCI-H2073. b , A549 cells were stably transfected with lentivirus containing control or Caspase-8 shRNA (Cap8 KD). Caspase-8, p-Src, c-Src, E-cad and β-actin in total cell lysates (TCLs) were detected by western blot. c , Caspase-8-deficient H522 cells were stably transfected with a control vector or wild-type Caspase-8 via adenovirus. Caspase-8, p-Src, c-Src, E-cad and β-actin in TCLs were detected by western blot. d , The TCLs of A549 and H522 cells in which c-Src was activated were subjected to immunoprecipitation (IP) using an anti-E-cadherin antibody. Ubiquitinated (Ubi-) E-cadherin was detected by western blot ( upper blot ). The blot was then stripped and reprobed for RNF43 ( second from upper panel ). RNF43, E-cadherin and β-actin were in TCLs detected by western blot ( lower blot ). e , A549 cells were allowed to attach to dishes for 12 h and then assessed by confocal microscopy using antibodies against E-cadherin and RNF43. Scale bars, 10 μm. f , E-cadherin mRNA was examined in A549 + control/Caspase-8 shRNA cells (Casp8 KD) and in H522 + control vector/wild-type Caspase-8 cells

    Techniques Used: Western Blot, Stable Transfection, Transfection, shRNA, Plasmid Preparation, Immunoprecipitation, Confocal Microscopy

    RNF43-induced E-cadherin ubiquitination and degradation initiated EMT phenotype via allowing β-catenin to translocate into the nucleus in a c-Src-dependent manner. a , A549 cells were stably transfected with the lentiviral control shRNA, RNF43 shRNA, or c-Src shRNA. Snail, Slug, Twist, E-cadherin (E-cad), Vimentin, Fibronectin, N-cadherin (N-cad), and β-actin in total cell lysates (TCLs) were detected by western blot. b , A549 cells stably transfected with lentiviral control shRNA, RNF43 shRNA, or c-Src shRNA were seeded overnight. TCLs were subjected to immunoprecipitation (IP) using an anti-E-cadherin antibody. Ubiquitinated E-cadherin was detected by western blot with an anti-ubiquitin antibody ( upper blot ). Phospho-β-catenin (p-β-catenin), β-catenin, GSK-3β, RNF43, and β-actin in TCLs were detected by western blot ( middle blot ). β-catenin was detected in the nuclear extract of A549 cells ( lower blot ). c , The TCLs of A549 cells stably transfected with lentiviral control shRNA, RNF43 shRNA, or c-Src shRNA were subjected to IP using an anti-β-catenin antibody. E-cadherin, GSK-3β, TCF-4, and β-catenin were detected by western blot. d , A549 cells were treated with an shRNA either not targeting TCF-4 (Control) or targeting TCF-4 (TCF-4). The in vitro β-catenin antibody 7A7 was delivered into A549 cells. Immunoblot analysis of LaminA/C (loading control), TCF-4, E-cad, Vimentin, and nuclear/total β-catenin was performed using appropriate antibodies. e , A549 cells were treated with an shRNA either not targeting (Control) or targeting TCF-4 (TCF-4). The in vitro β-catenin antibody 7A7 was delivered into A549 cells. The mRNA levels of E-cad, Vimentin, and RNF43 were examined by RT-PCR. GAPDH mRNA was used to confirm equal loading. f and g , β-catenin and TCF-4 chromatin immunoprecipitation (ChIP) in A549 cells. PCR was carried out using primers specific for the promoter regions of E-cad, Vimentin, and RNF43. One-fifth of the input DNA from each sample was also amplified and designated as Input. h , Schematic representation of reporter plasmids containing the control vector, E-cadherin promoter, Vimentin promoter, Vimentin promoter with WRE deletion (Vim mut), RNF43 promoter, and RNF43 promoter with WRE deletion (RNF43 mut). i , A549 cells were transiently transfected with the reporter plasmids described in f . Luciferase activities were measured in triplicate (mean ± SD, t test, *, P < 0.05)
    Figure Legend Snippet: RNF43-induced E-cadherin ubiquitination and degradation initiated EMT phenotype via allowing β-catenin to translocate into the nucleus in a c-Src-dependent manner. a , A549 cells were stably transfected with the lentiviral control shRNA, RNF43 shRNA, or c-Src shRNA. Snail, Slug, Twist, E-cadherin (E-cad), Vimentin, Fibronectin, N-cadherin (N-cad), and β-actin in total cell lysates (TCLs) were detected by western blot. b , A549 cells stably transfected with lentiviral control shRNA, RNF43 shRNA, or c-Src shRNA were seeded overnight. TCLs were subjected to immunoprecipitation (IP) using an anti-E-cadherin antibody. Ubiquitinated E-cadherin was detected by western blot with an anti-ubiquitin antibody ( upper blot ). Phospho-β-catenin (p-β-catenin), β-catenin, GSK-3β, RNF43, and β-actin in TCLs were detected by western blot ( middle blot ). β-catenin was detected in the nuclear extract of A549 cells ( lower blot ). c , The TCLs of A549 cells stably transfected with lentiviral control shRNA, RNF43 shRNA, or c-Src shRNA were subjected to IP using an anti-β-catenin antibody. E-cadherin, GSK-3β, TCF-4, and β-catenin were detected by western blot. d , A549 cells were treated with an shRNA either not targeting TCF-4 (Control) or targeting TCF-4 (TCF-4). The in vitro β-catenin antibody 7A7 was delivered into A549 cells. Immunoblot analysis of LaminA/C (loading control), TCF-4, E-cad, Vimentin, and nuclear/total β-catenin was performed using appropriate antibodies. e , A549 cells were treated with an shRNA either not targeting (Control) or targeting TCF-4 (TCF-4). The in vitro β-catenin antibody 7A7 was delivered into A549 cells. The mRNA levels of E-cad, Vimentin, and RNF43 were examined by RT-PCR. GAPDH mRNA was used to confirm equal loading. f and g , β-catenin and TCF-4 chromatin immunoprecipitation (ChIP) in A549 cells. PCR was carried out using primers specific for the promoter regions of E-cad, Vimentin, and RNF43. One-fifth of the input DNA from each sample was also amplified and designated as Input. h , Schematic representation of reporter plasmids containing the control vector, E-cadherin promoter, Vimentin promoter, Vimentin promoter with WRE deletion (Vim mut), RNF43 promoter, and RNF43 promoter with WRE deletion (RNF43 mut). i , A549 cells were transiently transfected with the reporter plasmids described in f . Luciferase activities were measured in triplicate (mean ± SD, t test, *, P < 0.05)

    Techniques Used: Stable Transfection, Transfection, shRNA, Western Blot, Immunoprecipitation, In Vitro, Reverse Transcription Polymerase Chain Reaction, Chromatin Immunoprecipitation, Amplification, Plasmid Preparation, Luciferase

    c-Src underlay RNF43-mediated E-cadherin ubiquitination through E-cadherin phosphorylation at tyrosine 797. a , H522 cells were stably transfected with wild-type c-Src (Src WT) and a constitutively active c-Src, Src Y527F. p-Src, c-Src, E-cadherin (E-cad), Vimentin, RNF43, total β-catenin, and β-actin via adenovirus and detected by western blot analysis of total cell lysates (TCLs) ( Upper blot ). β-catenin in the nuclear extract was evaluated using an antibody against β-catenin ( lower blot ). b , TCLs were subjected to immunoprecipitation (IP) using an anti-E-cadherin antibody. Ubiquitinated E-cadherin was detected with an anti-ubiquitin antibody. p-Src, RNF43, nonspecific phosphorylated tyrosine of E-cadherin (p-Tyr-100), and E-cadherin in the immunocomplex were detected by western blot. c , EMT morphological changes and metastatic incidences in H522 cells transfected with Src WT and Src Y527F ( χ 2 test, *, P < 0.05). Scale bars, 50 μm. d , Tyrosine 797 of E-cadherin was conserved across various species ( upper panel ). MALDI-mass spectrometry analysis of CNBr-cleaved endogenous E-cadherin expression in A549 cells with or without endogenous c-Src ( lower panel ). e , E-cadherin-knockdown A549 cells transfected with unmutated E-cadherin (E-cad WT) or E-cadherin mutated at Y755-757F (E-cad Y755-757F) or Y797F (E-cad Y797F) were lysed to obtain TCLs. E-cadherin (anti-HA) was immunoprecipitated from TCLs and probed for ubiquitin-E-cadherin, p-Src, nonspecific phosphorylated tyrosine of E-cadherin, RNF43, and E-cadherin (anti-HA) by western blot. f , E-cadherin-knockdown A549 cells transfected with HA-tagged E-cad WT, E-cad Y755-757F, or E-cad Y797F were lysed to obtain TCLs. p-Src, c-Src, Vimentin, E-cadherin (anti-HA), RNF43, total β-catenin, and β-actin were detected by western blot analysis of the TCLs ( upper blot ). Nuclear extracts were subjected to western blot analysis of β-catenin ( lower blot ). g , EMT morphological changes and metastatic incidences in E-cadherin-knockdown cells transfected with HA-tagged E-cad WT, E-cad Y755-757F, or E-cad Y797F ( χ 2 test, *, P < 0.05). Scale bars, 50 μm
    Figure Legend Snippet: c-Src underlay RNF43-mediated E-cadherin ubiquitination through E-cadherin phosphorylation at tyrosine 797. a , H522 cells were stably transfected with wild-type c-Src (Src WT) and a constitutively active c-Src, Src Y527F. p-Src, c-Src, E-cadherin (E-cad), Vimentin, RNF43, total β-catenin, and β-actin via adenovirus and detected by western blot analysis of total cell lysates (TCLs) ( Upper blot ). β-catenin in the nuclear extract was evaluated using an antibody against β-catenin ( lower blot ). b , TCLs were subjected to immunoprecipitation (IP) using an anti-E-cadherin antibody. Ubiquitinated E-cadherin was detected with an anti-ubiquitin antibody. p-Src, RNF43, nonspecific phosphorylated tyrosine of E-cadherin (p-Tyr-100), and E-cadherin in the immunocomplex were detected by western blot. c , EMT morphological changes and metastatic incidences in H522 cells transfected with Src WT and Src Y527F ( χ 2 test, *, P < 0.05). Scale bars, 50 μm. d , Tyrosine 797 of E-cadherin was conserved across various species ( upper panel ). MALDI-mass spectrometry analysis of CNBr-cleaved endogenous E-cadherin expression in A549 cells with or without endogenous c-Src ( lower panel ). e , E-cadherin-knockdown A549 cells transfected with unmutated E-cadherin (E-cad WT) or E-cadherin mutated at Y755-757F (E-cad Y755-757F) or Y797F (E-cad Y797F) were lysed to obtain TCLs. E-cadherin (anti-HA) was immunoprecipitated from TCLs and probed for ubiquitin-E-cadherin, p-Src, nonspecific phosphorylated tyrosine of E-cadherin, RNF43, and E-cadherin (anti-HA) by western blot. f , E-cadherin-knockdown A549 cells transfected with HA-tagged E-cad WT, E-cad Y755-757F, or E-cad Y797F were lysed to obtain TCLs. p-Src, c-Src, Vimentin, E-cadherin (anti-HA), RNF43, total β-catenin, and β-actin were detected by western blot analysis of the TCLs ( upper blot ). Nuclear extracts were subjected to western blot analysis of β-catenin ( lower blot ). g , EMT morphological changes and metastatic incidences in E-cadherin-knockdown cells transfected with HA-tagged E-cad WT, E-cad Y755-757F, or E-cad Y797F ( χ 2 test, *, P < 0.05). Scale bars, 50 μm

    Techniques Used: Stable Transfection, Transfection, Western Blot, Immunoprecipitation, Mass Spectrometry, Expressing

    Frz8 was required for the RNF43-induced ubiquitination of phosphorylated E-cadherin. a , Immunoblot analysis of Frz8, Frz2, Dishevelled 3 (Dvl3), LGR6, and β-actin in A549 and H522 cells. b , A549 and H522 cells stably transfected with control shRNA or RNF43 shRNA (RNF43 KD) via adenovirus were seeded overnight. The total cell lysates (TCLs) were subjected to immunoprecipitation (IP) using an anti-Frz8 antibody. Ubiquitinated Frz8 was detected by western blot with an anti-ubiquitin antibody ( upper blot ). Frz8 and RNF43 in the TCLs were detected by western blot ( lower blot ). c , A549 cells stably transfected with control shRNA or Frz8 shRNA (Frz8 KD) via lentivirus were seeded overnight. The TCLs were subjected to IP using an anti-E-cadherin antibody. Ubiquitinated E-cadherin was detected by western blot with an anti-ubiquitin antibody ( upper blot ). E-cadherin, Frz8, and β-actin in the TCLs were detected by western blot ( lower blot ). d , Schematic representation of reporter plasmids containing full-length RNF43 and two truncated versions of RNF43 as shown. e , RNF43-knockdown A549 cells stably transfected with RNF43, RNF43-R, or RNF43-P via adenovirus were seeded overnight. The TCLs were subjected to IP using anti-E-cadherin and anti-HA antibodies. Ubiquitinated E-cadherin, E-cadherin, Frz8, and HA were detected by western blot ( upper and middle blot ). E-cadherin and β-actin in the TCLs were detected by western blot ( lower blot ). f , A549 cells treated with DMSO (Control) or monoclonal antibodies (10.0 mmol/L) against the cysteine-rich domain (CRD) of Frz8 and the RNF43 protease domain (PA) were seeded overnight. The TCLs were subjected to IP using an anti-E-cadherin antibody. Ubiquitinated E-cadherin, RNF43, and E-cadherin were detected by western blot ( upper blot ). E-cadherin, Vimentin, and β-actin in the TCLs were detected by western blot ( middle blot ). β-catenin was detected in the nuclear extract ( lower blot ). g , A549 cells treated with DMSO (Control) or monoclonal antibodies (10.0 mmol/L) against the cysteine-rich domain (CRD) of Frz8 and the RNF43 protease domain (PA) were seeded overnight. The TCLs were subjected to IP using an anti-RNF43 antibody. Frz8, RNF43, and E-cadherin were detected by western blot. h , EMT morphological changes and metastatic incidences in A549 cells treated with DMSO (Control) or monoclonal antibodies (10.0 mmol/L) against the cysteine-rich domain (CRD) of Frz8 and the RNF43 protease domain (PA) ( χ 2 test, *, P < 0.05). Scale bars, 50 μm. i , A549 cells treated with DMSO (Control) and RSOP1–4 were seeded overnight. The TCLs were subjected to IP using anti-E-cadherin and anti-Frz8 antibodies. Ubiquitinated E-cadherin and RNF43 were detected by western blot ( upper and middle blot ). E-cadherin and β-actin in the TCLs were detected by western blot ( lower blot )
    Figure Legend Snippet: Frz8 was required for the RNF43-induced ubiquitination of phosphorylated E-cadherin. a , Immunoblot analysis of Frz8, Frz2, Dishevelled 3 (Dvl3), LGR6, and β-actin in A549 and H522 cells. b , A549 and H522 cells stably transfected with control shRNA or RNF43 shRNA (RNF43 KD) via adenovirus were seeded overnight. The total cell lysates (TCLs) were subjected to immunoprecipitation (IP) using an anti-Frz8 antibody. Ubiquitinated Frz8 was detected by western blot with an anti-ubiquitin antibody ( upper blot ). Frz8 and RNF43 in the TCLs were detected by western blot ( lower blot ). c , A549 cells stably transfected with control shRNA or Frz8 shRNA (Frz8 KD) via lentivirus were seeded overnight. The TCLs were subjected to IP using an anti-E-cadherin antibody. Ubiquitinated E-cadherin was detected by western blot with an anti-ubiquitin antibody ( upper blot ). E-cadherin, Frz8, and β-actin in the TCLs were detected by western blot ( lower blot ). d , Schematic representation of reporter plasmids containing full-length RNF43 and two truncated versions of RNF43 as shown. e , RNF43-knockdown A549 cells stably transfected with RNF43, RNF43-R, or RNF43-P via adenovirus were seeded overnight. The TCLs were subjected to IP using anti-E-cadherin and anti-HA antibodies. Ubiquitinated E-cadherin, E-cadherin, Frz8, and HA were detected by western blot ( upper and middle blot ). E-cadherin and β-actin in the TCLs were detected by western blot ( lower blot ). f , A549 cells treated with DMSO (Control) or monoclonal antibodies (10.0 mmol/L) against the cysteine-rich domain (CRD) of Frz8 and the RNF43 protease domain (PA) were seeded overnight. The TCLs were subjected to IP using an anti-E-cadherin antibody. Ubiquitinated E-cadherin, RNF43, and E-cadherin were detected by western blot ( upper blot ). E-cadherin, Vimentin, and β-actin in the TCLs were detected by western blot ( middle blot ). β-catenin was detected in the nuclear extract ( lower blot ). g , A549 cells treated with DMSO (Control) or monoclonal antibodies (10.0 mmol/L) against the cysteine-rich domain (CRD) of Frz8 and the RNF43 protease domain (PA) were seeded overnight. The TCLs were subjected to IP using an anti-RNF43 antibody. Frz8, RNF43, and E-cadherin were detected by western blot. h , EMT morphological changes and metastatic incidences in A549 cells treated with DMSO (Control) or monoclonal antibodies (10.0 mmol/L) against the cysteine-rich domain (CRD) of Frz8 and the RNF43 protease domain (PA) ( χ 2 test, *, P < 0.05). Scale bars, 50 μm. i , A549 cells treated with DMSO (Control) and RSOP1–4 were seeded overnight. The TCLs were subjected to IP using anti-E-cadherin and anti-Frz8 antibodies. Ubiquitinated E-cadherin and RNF43 were detected by western blot ( upper and middle blot ). E-cadherin and β-actin in the TCLs were detected by western blot ( lower blot )

    Techniques Used: Western Blot, Stable Transfection, Transfection, shRNA, Immunoprecipitation

    Related Articles

    Recombinant:

    Article Title: Structural characterization of SLYM—a 4th meningeal membrane
    Article Snippet: Dipeptidyl peptidase IV (DPP4) , Mouse myeloma cell line NS0-derived recombinant mouse DPPIV/CD26 Ser29-His760 Accession # P28843 , R&D Systems (AF594) , Goat IgG , 1:200 , AB_355739 , . .. E-Cadherin (E-Cad) , Recombinant full length protein , Abcam (ab231303) , Mouse IgG1 , 1:100 , AB_2923285 , . .. Fibroblast Antibody (ER-TR7) , Isolated C3H thymic stromal cells , Novus (NB100-64932) , Rat IgG2a , 1:300 , AB_963381 , .

    Incubation:

    Article Title: Knockdown of ABHD11‑AS1 prevents the procession of TNBC by upregulating miR‑199a‑5p
    Article Snippet: .. Subsequently, the tissues were blocked in 5% BSA (Roche Diagnostics) for 20 min at room temperature, and then incubated with primary antibodies, including anti-N-Cadherin (1:100), anti-Snail (1:100; cat. no. ab224731; Abcam) and anti-E-Cadherin (1:100; cat. no. ab40772; Abcam) at 4 ̊C overnight. .. Subsequently, the tissues were blocked in 5% BSA (Roche Diagnostics) for 20 min at room temperature, and then incubated with primary antibodies, including anti-N-Cadherin (1:100), anti-Snail (1:100; cat. no. ab224731; Abcam) and anti-E-Cadherin (1:100; cat. no. ab40772; Abcam) at 4 ̊C overnight.

    Article Title: Placenta mesenchymal stem cell-derived extracellular vesicles alleviate liver fibrosis by inactivating hepatic stellate cells through a miR-378c/SKP2 axis
    Article Snippet: Following the transfer to the polyvinylidene fluoride (PVDF, Bio-Rad, CA, USA) membrane, samples were blocked in a 5% BSA solution. .. Then, membranes were incubated with primary antibody solution (anti-collagen I, anti-CD63, CD81, CD9, Abcam, USA; anti-α-smooth muscle actin, Sigma, USA; E-cadherin, Vimentin, Ub, proteintech, China) at a ratio of 1:1000 overnight at 4 °C. .. After washing three times in TBST, samples were incubated in solution of horseradish peroxidase-linked secondary (Thermo, NY, USA) for 2 h at room temperature.



    Similar Products

    90
    Biotechnology Information microarray and high-throughput sequencing database
    Microarray And High Throughput Sequencing Database, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microarray+and+high-throughput+sequencing+database/microarray/pm40564394-32-19-4
    Average 90 stars, based on 1 article reviews
    microarray and high-throughput sequencing database - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results